Evolus (EOLS) Interest Expenses (2017 - 2026)
Evolus (EOLS) posted Interest Expenses of $4.0 million for Q1 2026, down 52.37% on a QoQ basis from $8.3 million in Q4 2025, and down 9.97% year-over-year from $4.4 million in Q1 2025.
Evolus (EOLS) Interest Expenses (2017 - 2026) Analysis & Trends
Evolus' Interest Expenses history runs 10 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- Quarterly Interest Expenses fell 9.97% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.8 million (up 20.7% YoY) and the FY2025 annual result came in at $19.7 million, down 84.23% from the prior year.
- Interest Expenses was $4.0 million for Q1 2026 at Evolus, down from $8.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $15.6 million in Q2 2022 and bottomed at $2.3 million in Q4 2022.
- A 5-year average of $6.3 million and a median of $4.7 million in 2024 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 310.02% in 2022, while the deepest fall reached 99.57% in 2022.
- Evolus' Interest Expenses stood at $2.3 million in 2022, then surged by 109.71% to $4.9 million in 2023, then sank by 31.3% to $3.4 million in 2024, then surged by 146.7% to $8.3 million in 2025, then tumbled by 52.37% to $4.0 million in 2026.
- Business Quant data shows EOLS's Interest Expenses at $4.0 million in Q1 2026, $8.3 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 3.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98 Mn |
| Mar 31, 2026 | 3.98 Mn |
| Dec 31, 2025 | 8.35 Mn |
| Dec 31, 2025 | 8.35 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 4.92 Mn |
| Dec 31, 2023 | 4.92 Mn |